2Howell A, Johnston SRD. Selective estrogen receptor modulators (SERMs). In: RobertsonJFR, Nicholson RI, Hayes DF, eds. Endocrine therapy of breast cancer [ M]. London: Martin Dunitz, 2002. 45-62.
4Osborne CK. Tamoxifen in the treatment of breast cancer [J]. New Engl J Med, 1998, 339 (22): 1609- 1618.
5Hayes DF, Robertson JFR. Overview and concepts of endocrine therapy. In: Robertson JFR, Nicholson RI, Hayes DF, eds. Endocrine therapy of breast cancer [ M]. London: Martin Dunitz, 2002. 3-10.
6Blamey RW, Jonat W, Kaufmann M, et al. Goserelin depot in the treatment of premenopausal advanced breast cancer [J]. Eur J Cancer, 1992, 28A: 810-814.
8Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [ J ]. Lancet, 1999, 353: 1993-2000.
9Baum M, Buzdar AU, Cuzik J, et al. Anastrozole alone or in conrbination with Tamoxifen versus Tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial [J]. Lancet, 2002, 359: 2131.
10Winer EP, Hudis C, Burstein HJ, et al. American Society of Chnical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 [J]. J Clin Oncol, 2005, 23 (3): 619-629.
6[2]Henderson C,Berry DA,Demetri GD,et a1.Improved outcomes from adding sequential paelitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.J Clin Oncol,2003,21(6):976～983
7[3]Steven D Heys,Tarun Sarkar,Andrew W Hutcheon,et al. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.Expert Opinion on Pharmacotherapy, 2004,5(10):2147～2157
8[4]Citron ML,Berry DA,Cirrineione C,et a1.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974l.J Clin Oncol,2003,21(8):1431～1439
9[9]Early Breast Cancer Trialists'Collaborative Group.Tamoxifen for early breast cancer:an overview of the randomized trials.Lancet,1998,351:1451
10[10]Coombes RC,Hall E,Gibson LJ,et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.N Engl J Med,2004,350:1081
